Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new genetic study of the bacteria that cause pleurisy has shown most cases involve more than one type of bacterium, and revealed which bacterial combinations cause the most serious infections.

Gram Negative Bacteria © Source: Shutterstock/ www.royaltystockphoto.com

Pleural infection is a common and severe disease with high morbidity and mortality worldwide. Pleural infection occurs when bacteria invade the pleural space, which is the area in-between the lungs and the chest wall. Patients need hospitalisation, which could last from several days to weeks. Conventional bacterial culture techniques fail to identify the pathogen in approximately 40% of cases, which leads to broad-spectrum antibiotics being used as treatment.

In a new study published in The Lancet Microbe, an international collaboration of scientists led by researchers from Oxford University’s Nuffield Department of Medicine has found that pleural infection was predominately caused by more than one microbe at a time.

The researchers used genetic analysis to study the entire range of bacteria in patients with pleural infection, to help them asses the correlation between bacterial patterns and 1-year patient survival. This is the largest translational metagenomics study of pleural infection in adults, combining high-throughput discovery with high-quality prospective clinical data. The study used samples collected from a previous clinical trial led by John Corcoran and Professor Najib Rahman.

Today’s study was jointly led by Najib Rahman, Professor of Respiratory Medicine and Nikolaos Kanellakis of the Nuffield Department of Medicine’s Experimental medicine Division.

Nikolaos Kanellakis said: ‘Improving our understanding of the underlying biology of pleural infection has the potential to improve patients' clinical management and potentially shorten hospital stays, minimise complications from antibiotic use, and reduce health-care costs.

‘Understanding the crosstalk between human and bacterial cells, and the interactions between bacteria to form biofilms, might also help us to develop non-antibiotic-based treatments in the future.

‘Importantly, the establishment and use of a method for identifying pathogens without using the slower method of culturing bacterial plates in the lab, could one day lead to patients being given the most appropriate treatment much faster.’

The study also showed mixed anaerobes and other Gram-negative bacteria dominating community-acquired polymicrobial infection, whereas Streptococcus pneumoniae dominated in monomicrobial cases. Infections with anaerobes and bacteria of the Streptococcus anginosus group were associated with better survival, whereas Staphylococcus aureus and Enterobacteriaceae were linked with higher mortality.

The full paper, ‘The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing’, can be read in The Lancet Microbe.

This research was funded by the Chinese Academy of Medical Sciences (China Oxford Institute), National Institute for Health Research Oxford Biomedical Research Centre, UK Medical Research Council, Wellcome Trust, Oxfordshire Health Services Research Committee, and John Fell Fund.

Similar stories

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

New study provides important insights into TB correlates of protection

Researchers from the Nuffield Department of Medicine’s Jenner Institute have today reported the findings from a study investigating whether previously identified correlates of protection associated with the risk of tuberculosis (TB) disease could also be associated with the risk of infection from the bacteria that causes TB.

Therapeutic HIV vaccine achieves encouraging results

A phase I/IIa clinical trial that the Nuffield Department of Medicine's Jenner Institute collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was temporarily withdrawn.

Gene associated with better immune response after COVID-19 vaccination identified

Researchers from the Nuffield Department of Medicine have today reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines – identifying a particular gene associated with a high antibody response.

Monkeypox can spread widely within specialist hospital isolation rooms

A new study found viral monkeypox DNA on multiple surfaces, personal protective equipment, and in air samples in hospital isolation rooms. For some of the samples, the viral particles were capable of replicating and therefore could potentially infect other people.

New computational technique reveals changes to lung function post COVID-19 infection

To investigate whether the symptoms of ‘long-COVID’ are associated with any long-term damage that reduces the function of the lungs and respiratory system, a study led by University of Oxford researchers used a novel computational approach to assess how COVID-19 may affect long-term lung function.